Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Reduced mRNA expression in paraffin-embedded tissue identifies MLH1- and MSH2-deficient colorectal tumours and potential mutation carriers
Virchows Archiv, 07/03/08
Müller A et al. - In a trial to identify MLH1 or MSH2-deficient colorectal tumours, it was found that RT-PCR allows relative quantification of MMR gene mRNA expression in formalin-fixed and paraffin-embedded tissue, and this approach enables quantification of haploinsufficiency due to nonsense-mediated mRNA decay in normal tissue and B-lymphocytes from pts carrying MSH2 germline mutations and may be useful for identification of asymptomatic carriers of pathogenic germline mutations
Methods- Based on the principle of nonsense-mediated mRNA decay, MLH1 or MSH2-deficient colorectal tumours were identified through relative quantification of mRNA expression with real-time PCR (RT-PCR) analysis
- MLH1 and MSH2 mRNAs were almost equally expressed as defined by MLH1 to MSH2 transcript ratio in 16 microsatellite stable, mismatch repair (MMR) proficient tumours
- A close correlation between loss of protein expression and MMR–mRNA levels was found in highly microsatellite instable (MSI-H) tumours deficient of MLH1 or MSH2
- MLH1/MSH2 ratio was low in 11 sporadic and 9 hereditary MLH1-deficient carcinomas, whereas the ratio was high in 17 MSH2-deficient hereditary non-polyposis colorectal cancer (HNPCC) associated carcinomas
- In the normal tissues of HNPCC pts with MSH2 mutations, the MLH1/MSH2 transcript ratios were significantly elevated as compared with the ratios of normal mucosa in pts with MMR-proficient tumours
- Analysis of B-lymphocytes of HNPCC pts with proven MMR gene mutation confirmed these findings
| Previous Article | Next Article |
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Expression of ER-α36, a novel variant of estrogen receptor-α, and resistance to tamoxifen treatment in breast cancer
Journal of Clinical Oncology, 06/04/09
Clinical features of the most common fusion genes in childhood acute lymphoblastic leukemia
Medical Oncology, 06/05/09
Single-center series and systematic review of randomized controlled trials of malignancies in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis receiving anti-tumor necrosis factor-alpha; therapy: Is there a need for more comprehensive screening procedures?
Arthritis Care and Research , 06/03/09
Today in Colorectal Cancer/Polyps...keeping you current
Receive free subspecialty "5-minute updates" via email
Synchronous colorectal liver metastases: is it time to reconsider traditional paradigms of management
Annals of Surgical Oncology, 06/12/09
Colorectal cancer screening among first-degree relatives of colorectal cancer patients
Annals of Surgical Oncology, 06/03/09
Risk factors for complications after laparoscopic surgery in colorectal cancer patients: experience of 401 cases at a single institution
World Journal of Surgery, 06/12/09
Sponsor
Article Search
Sponsor


See Latest Articles


